TQB3125
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 11, 2026
Preclinical activity of TQB3125, an orally bioavailable pan-RAS(ON) molecular glue for KRAS-mutant pancreatic cancer
(EORTC-NCI-AACR 2026)
- "Abstract will be available as of 4 November (with consent of the author)"
Preclinical • Oncology • Pancreatic Cancer • Solid Tumor • KRAS • RAS
1 to 1
Of
1
Go to page
1